Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.38 |
| ▸ | RELA | Q04206 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | IDH1 | O75874 | 1/20 | 0.37 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6042308 | 0.77 | HRH1 (0.52) | NPC1NFKB1RAB9ANFKB2RELA | |
| SCHEMBL27843023 | 0.77 | HIF1A (0.49) | NPC1NFKB1RAB9ANFKB2RELA | |
| SCHEMBL6041956 | 0.77 | NPC1 (0.47) | NPC1NFKB1RAB9ANFKB2RELA | |
| SCHEMBL18876359 | 0.77 | NPC1 (0.44) | NPC1NFKB1RAB9ANFKB2RELA | |
| SCHEMBL10639413 | 0.74 | FFAR1 (0.48) | IDH1MMP9 | |
| SCHEMBL18534273 | 0.73 | — | — | |
| SCHEMBL14047227 | 0.72 | MCHR1 (0.42) | NPC1NFKB1RAB9ANFKB2RELA | |
| SCHEMBL12723085 | 0.72 | SRC (0.39) | L3MBTL1NPC1NFKB1RAB9ANFKB2 | |
| SCHEMBL25304675 | 0.72 | RAB9A (0.45) | L3MBTL1NPC1NFKB1RAB9ANFKB2 | |
| SCHEMBL2554715 | 0.72 | RAB9A (0.45) | L3MBTL1NPC1NFKB1RAB9ANFKB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024096753-A1 | NEK7 DEGRADERS AND METHODS OF USE THEREOF | CAPTOR THERAPEUTICS S.A. (PL) | 2024-05-10 | — | — | WO | disclosed |